Better Times Ahead For Evaxion Biotech A/S ADR (NASDAQ: EVAX)?
Beacon Capital Management LLC has recently announced that it has increased stake in Evaxion Biotech A/S ADR (NASDAQ:EVAX) by 606.77%. After grabbing 48633.0 shares, the institutional investor is now in possession of 41752.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.18% having worth around $33362.0. Moreover, AE […]
